Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150.
Saved in:
| Title: | Development of High-Titer Antidrug Antibodies in a Phase 1b/2a Infant Clesrovimab Trial Are Associated With RSV Exposure Beyond Day 150. |
|---|---|
| Authors: | Thambi, Nithya1 (AUTHOR), Phuah, Jia Yao1 (AUTHOR), Staupe, Ryan P1 (AUTHOR), Tobias, Lori M2,3 (AUTHOR), Cao, Yu2,3 (AUTHOR), McKelvey, Troy3 (AUTHOR), Railkar, Radha A2,4 (AUTHOR), Aliprantis, Antonios O5 (AUTHOR), Arriola, Carmen Sofia1 (AUTHOR), Maas, Brian M2,6 (AUTHOR), Vora, Kalpit A1 (AUTHOR) |
| Source: | Journal of Infectious Diseases. Mar2025, Vol. 231 Issue 3, pe488-e496. 9p. |
| Database: | Environment Complete |
| ISSN: | 00221899 |
|---|---|
| DOI: | 10.1093/infdis/jiae582 |
